9 nov 2021
CPhI Worldwide 2021
Daewoong Pharmaceutical Co.,Ltd

Daewoong Pharmaceutical Co.,Ltd

Exhibitor at CPhI Worldwide 2021 stand stand 3L21

About us

Since its establishment in 1945, Daewoong Pharmaceutical has grown to become one of the top 5 pharmaceutical companies in Korea. With its strong and competent in-house R&D and qualified manufacturing facilities (cGMP), Daewoong provides a total healthcare solution to patients across the globe. We manufacture various products (ETC&OTC) including Biologic, Chemical, Medical Device, etc. 

Products: Finished Dosage Formulations (Biologic & Chemical), APIs, Antibiotics, Enzymes
Interests: In-licencing, Out-licensing, CDMO

Company Highlights
7 Manufacturing Sites (3 Overseas, 4 Korea)
6 Billion Units manufactured annually
Exporting to 90 Countries
70 Years of Experience
3 Overseas R&D centers
8 Global Sales Networks (Branch & Corporation)
770+ Employees working in R&D and Manufacturing (CDMO related) area
678 Drug Approvals up to date

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: APIs (Active Pharmaceutical Ingredients) |Biopharmaceuticals |Biosimilars More

Products featured at CPhI Worldwide 2021

Daewoong Pharmaceutical Co.,Ltd

Event information

CPhI Worldwide 2021

9-11 November 2021 Fiera Milano, Milan, Italy Visit us at stand 3L21